CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 3,171 shares at $17.05 ($54,066)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 4,919 shares at $18.23 ($89,673)
- 144 Insider Sale of Securities
- 10-K Report Annual Report
- 8-K Event Results of operations
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 475 shares at $19.96 ($9,481)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 773 shares at $19.96 ($15,429)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Acquisition or sale completed
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale EVP, COO, HEAD OF COMMERCIAL sold 10,329 shares at $16.81 ($173,630)
- 4 Open-market sale PRINCIPAL ACCOUNTING OFFICER sold 4,073 shares at $16.81 ($68,467)
- 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 10,259 shares at $16.81 ($172,454)
- SC 13G/A Stake Amended Statement of Ownership
Page 6 of 70 · 1,382 filings